Tuis539871 • BOM
add
Thyrocare Technologies Ltd
Vorige sluiting
₹970,35
Dagwisseling
₹945,60 - ₹975,90
Jaarwisseling
₹545,05 - ₹1 002,00
Markkapitalisasie
50,65 mjd INR
Gemiddelde volume
6,71 k
P/V-verhouding
61,01
Dividend-opbrengs
1,88%
Primêre beurs
NSE
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (INR) | Sep. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 1,77 mjd | 19,84% |
Bedryfskoste | 616,60 m | 22,27% |
Netto inkomste | 266,70 m | 31,12% |
Netto winsgrens | 15,04 | 9,46% |
Wins per aandeel | 4,98 | — |
EBITDA | 474,35 m | 27,82% |
Effektiewe belastingkoers | 28,15% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (INR) | Sep. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 1,38 mjd | 38,47% |
Totale bates | 5,97 mjd | 0,74% |
Totale aanspreeklikheid | 1,08 mjd | 3,20% |
Totale ekwiteit | 4,89 mjd | — |
Uitstaande aandele | 53,45 m | — |
Prys om te bespreek | 10,62 | — |
Opbrengs op bates | — | — |
Opbrengs op kapitaal | 16,35% | — |
Kontantvloei
Netto kontantverandering
| (INR) | Sep. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | 266,70 m | 31,12% |
Kontant van bedrywe | — | — |
Kontant van beleggings | — | — |
Kontant van finansiering | — | — |
Netto kontantverandering | — | — |
Beskikbare kontantvloei | — | — |
Meer oor
Thyrocare Technologies Limited is an Indian multinational chain of diagnostic and preventive care laboratories, headquartered in Navi Mumbai. As of 2021, the company has a total of 1,122 outlets and collection centers across India and parts of Nepal, Bangladesh and the Middle East.
On 26 June 2021, Indian e-pharmacy and online healthcare aggregator PharmEasy's parent API Holdings acquired a 66.1% controlling stake in Thyrocare, making Thyrocare the first Indian listed company to be acquired by a startup. Wikipedia
Gestig
1996
Hoofkwartier
Webwerf
Werknemers
1 693
